Journal
ONCOTARGET
Volume 7, Issue 45, Pages 72833-72844Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.12023
Keywords
Deleted in malignant brain tumors 1 (DMBT1); CRNDE; c-IAP1; migration and invasion; GBC carcinogenesis
Categories
Funding
- National Natural Science Foundation of China [81272728, 81272722, 81502004]
- Foundation of Science and Technology Commission of Shanghai Municipality, China [16411952000, 11JC1416202, 10411955500]
Ask authors/readers for more resources
Deleted in malignant brain tumors 1 (DMBT1) is deleted during cancer progression and as a potential tumor-suppressor gene in various types of cancer. However, its role in Gallbladder cancer remains poorly understood. DMBT1 has low-expression and deletion of copy number were detected in normal tissues and GBC cancer tissues by qRT-PCR. Knockdown of DMBT1 increased migration and invasion and overexpressed DMBT1 impaired migration and invasion in GBC cells. We also evaluated the molecular mechanism of DMBT1 by RNA sequencing and GSEA analysis. RNA-Pulldown and RIP assay authenticated CRNDE can specified binding with DMBT1 and c-IAP1. Downregulation of DMBT1 resulted in significant change of gene expression (at least 2-fold) in PI3K-AKT pathway, increased expression of MMP-9, JUK-1, ERK and AKT, activating PI3K-AKT pathway lead to GBC carcinogenesis. We for the first time reported, DMBT1 as a prognosis biomarker, is low-expressed in GBC tumors, and CRNDE act as a scaffold to recruit the DMBT1 and c-IAP1, promotes the PI3K-AKT pathway. Our study reveals DMBT1 may be an important contributor to GBC cancer development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available